|
LARS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.19540000120821E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.94009999965728E-07 |
| Normal-vs-Stage2 |
3.053700E-02 |
| Normal-vs-Stage3 |
1.152610E-04 |
| Normal-vs-Stage4 |
4.53859949622881E-10 |
| Stage1-vs-Stage2 |
8.829600E-01 |
| Stage1-vs-Stage3 |
2.306000E-01 |
| Stage1-vs-Stage4 |
1.924250E-03 |
| Stage2-vs-Stage3 |
3.201000E-01 |
| Stage2-vs-Stage4 |
2.287800E-02 |
| Stage3-vs-Stage4 |
1.259850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.69260000354643E-08 |
| Normal-vs-AfricanAmerican |
4.786500E-04 |
| Normal-vs-Asian |
7.530100E-02 |
| Caucasian-vs-AfricanAmerican |
6.986000E-01 |
| Caucasian-vs-Asian |
6.110800E-01 |
| AfricanAmerican-vs-Asian |
5.095000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.49249987105804E-10 |
| Normal-vs-Female |
2.226300E-02 |
| Male-vs-Female |
6.992000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.68559999999785E-05 |
| Normal-vs-Extreme_Weight |
5.10219999583228E-08 |
| Normal-vs-Obese |
2.40600000001034E-06 |
| Normal-vs-Extreme_Obese |
6.138800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.963200E-01 |
| Normal_Weight-vs-Obese |
5.968200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.745030E-01 |
| Extreme_Weight-vs-Obese |
5.217000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.174370E-01 |
| Obese-vs-Extreme_Obese |
1.765350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.49330000000093E-05 |
| Normal-vs-Age(41-60Yrs) |
1.1182000000387E-06 |
| Normal-vs-Age(61-80Yrs) |
8.26329999981112E-07 |
| Normal-vs-Age(81-100Yrs) |
8.224000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.221000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.864200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.921200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.532600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.047800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.875400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.92809999965959E-07 |
| Normal-VS-Type2 PRCC |
6.36349999999508E-05 |
| Normal-VS-KIRP CIMP |
1.09420000005134E-06 |
| Normal-VS-Unclassified PRCC |
6.139600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.064400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.749000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.690200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.184400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.399800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.068220E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.25370000048086E-07 |
| Normal-vs-N1 |
7.31910000384417E-08 |
| Normal-vs-N2 |
1.98969999998244E-06 |
| N0-vs-N1 |
2.190000E-01 |
| N0-vs-N2 |
3.407600E-01 |
| N1-vs-N2 |
6.414000E-01 |
|
|
